We expect weaker correlations between weight loss and the change in insulin secretion (compared to insulin sensitivity), as well as an independent association of low insulin secretion and insulin-resistant NAFLD with the non-remission of prediabetes. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.